
Why the FDA rejected a ‘breakthrough’ melanoma drug
The FDA rejected the promising skin cancer drug RP1 twice, leaving many puzzled and worried about what this means for other drug approvals

Why the FDA rejected a ‘breakthrough’ melanoma drug
The FDA rejected the promising skin cancer drug RP1 twice, leaving many puzzled and worried about what this means for other drug approvals

What you eat for lunch could influence your immune system just hours later
Our food choices could play an important, short-term role in how our bodies respond to infections, new research suggests


RFK, Jr., puts psychedelics on fast track to FDA review and approval
The U.S. Food and Drug Administration is seeking to accelerate the review process for three companies that are studying psilocybin and an MDMA-like drug as treatments for depression and PTSD

Congress grills RFK, Jr., about vaccines and cuts to health budget
The HHS secretary defended proposed budget cuts to science, his vaccine moves and health care costs on Capitol Hill on Thursday

Elizabeth Roboz Einstein was the determined genius behind a multiple sclerosis breakthrough
A Hungarian refugee who came to the U.S. with nothing but a diploma made a breakthrough discovery in the burgeoning field of neurochemistry

Dangerous microbes could be getting a hidden boost from climate change
Antibiotic-resistant bacteria are increasing, and a new study finds that extreme weather may be juicing their rise

The case for timing medical treatments to daily circadian rhythms
A growing field of research suggests that some medical treatments, such as cancer therapy or vaccines, might be more effective when given at certain times of the day

How your kidneys actually work — and what happens when they fail
Your kidneys silently filter 150 quarts of blood every single day — but what happens when they stop working?

A single course of antibiotics may reshape the gut microbiome for years
A study in Sweden found that some antibiotics affected microbial diversity in the gut more than others

Heart disease in young women projected to rise sharply by 2050
A new projection study estimates that nearly a third of women aged 20 to 44 will have been diagnosed with a cardiovascular disease by 2050

What if most medications were sold over the counter?
The FDA is reportedly considering broadening the types of drugs that can be sold without a prescription, a move some pharmacy experts say could raise safety risks

How a year of RFK, Jr., has changed American science
After a year of RFK, Jr., heading the Department of Health and Human Services, the “Make America Healthy Again” movement has upended science and medicine